CFG
BIO icon

Cooper Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cooper Financial Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-457
Closed -$219K – 317
2023
Q1 		$219K Buy
+457
New +$214K 0.06% 275
2022
Q1 		– Sell
-811
Closed -$613K – 249
2021
Q4 		$613K Buy
811
+10
+1% +$7.48K 0.23% 101
2021
Q3 		$598K Buy
801
+59
+8% +$44.2K 0.12% 115
2021
Q2 		$478K Buy
742
+41
+6% +$25K 0.1% 126
2021
Q1 		$400K Sell
701
-14
-2% -$8.29K 0.09% 146
2020
Q4 		$417K Sell
715
-19
-3% -$10.8K 0.09% 173
2020
Q3 		$378K Sell
734
-54
-7% -$27.4K 0.11% 130
2020
Q2 		$356K Buy
+788
New +$348K 0.12% 125

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Cooper Financial Group's BIO Position: Q2 2023 in Review

Cooper Financial Group sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 457 shares — an estimated $219K sold.

Cooper Financial Group first reported a position in BIO in Q2 2020 and held it in 8 quarters. The position peaked at $613K in Q4 2021. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Cooper Financial Group reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Cooper Financial Group sold 457 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $219K.
  • Cooper Financial Group first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 8 quarters.
  • Cooper Financial Group's Bio-Rad Laboratories Class A position peaked at $613K in Q4 2021.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Cooper Financial Group's 13F filing for Q2 2023, filed 7 Jul 2023.